New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 25, 2013
07:17 EDTDVADaVita price target raised to $73 from $63 at Piper Jaffray
Piper Jaffray raised its price target for DaVita to $73 after CMS released its final dialysis rebasing rule. Piper expects shares of DaVita to trade higher as it believes the final rule will drive 2014 estimates higher and improve sentiment. The firm keeps an Overweight rating on the stock.
News For DVA From The Last 14 Days
Check below for free stories on DVA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 23, 2014
06:16 EDTDVADaVita acquires three hemodialysis centers in Malaysia
Subscribe for More Information
April 16, 2014
09:51 EDTDVARevised CMS ruling favorable for dialysis providers, says Wells Fargo
Wells Fargo said the Centers for Medicare & Medicaid Services eliminated the impact of the rebase in its revised rules from for its proposed accountable care demonstration project for dialysis providers, which is a positive for the providers. The firm keeps an Outperform rating on DaVita HealthCare (DVA) and a Market Perform rating on Fresenius Medical (FMS).

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use